NEW YORK (GenomeWeb) – A large, international research team has taken a prospective look at the actual breast and ovarian cancer rates in individuals with known pathogenic mutations in the BRCA1 or BRCA2 genes.

"We have been able to provide the most precise estimates of age-specific risks to date," corresponding author Antonis Antoniou, a cancer genetic epidemiology researcher at the University of Cambridge, said in a statement. "These should provide more confidence in the counseling and clinical management of women with faults in the BRCA1 and BRCA2 genes."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.